Quick Heal Technologies Ltd
Quick Heal Technologies Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Enterprise business is expected to become the dominant revenue contributor soon, overtaking Consumer business, which is structurally declining. Quick Heal Technologies expects steady growth driven by both Consumer and Enterprise segments, with Enterprise set to take a larger revenue share soon (currently around 60-40 split).
From Quick Heal Technologies Ltd's Q2 FY26 earnings-call transcript · updated 26 Aug 2026.
Revenue & Sales Performance
- Enterprise business is expected to become the dominant revenue contributor soon, overtaking Consumer business, which is structurally declining.
- Total Addressable Market (TAM) is projected to increase from INR 1,800 crores to INR 4,000 crores.
- Enterprise segment expected to contribute around 80% of the INR 4,000 crores TAM; Consumer around 20%.
- International revenue currently constitutes about 20% of Enterprise revenue.
- Government segment and international markets targeted for significant growth.
- New products such as data privacy solutions, threat intelligence platforms, EDR, XDR, STI, and SMAP expected to drive growth.
- Focus on mid-market and SMB enterprises with 1,000-5,000 endpoints.
- Continued investments in R&D and sales/marketing to support revenue growth.
2 more points from Quick Heal Technologies Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Quick Heal Technologies Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company maintains a strong balance sheet with INR 191 crores cash balance as of 30th September 2025, offering flexibility for investments.
- They are actively evaluating options for M&A and strategic acquisitions aligned with their vision and roadmap.
- Investments in R&D remain a priority, with ongoing optimization through AI and automation to sustain product innovation.
- There are no specific disclosed plans for large current capex, but the firm continues expanding sales and marketing teams, especially for Enterprise growth.
2 more points from Quick Heal Technologies Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in IT - Software
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Quick Heal Technologies Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Quick Heal Technologies Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Quick Heal Technologies Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹49 Cr, net loss ₹20 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Quick Heal Technologies Ltd's management said in earlier quarters
- Q4 FY25 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY24 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY23 earnings call →
- Q2 FY23 earnings call →
Others in IT - Software this season
- Softtech Enginee (Q2 FY26)
Standalone: Rs 25.71 Cr (up from Rs 22.93 Cr in Q2 FY 2024-25) — approx. Key investor presentation takeaways from Softtech Engineers Ltd's Q2 FY26 investor pres
- Systango Tech (Q2 FY26)
Year-on-Year (YoY) revenue growth for H1-FY26 is 58.0% compared to H1-FY25 revenue of INR 288 million. Key investor presentation takeaways from Systango Technol
- 3i Infotech Ltd (Q2 FY26)
Q2 FY26 consolidated revenue from operations: ₹174.9 crore, a 2.5% increase quarter-on-quarter (QoQ) but a 2% decrease year-on-year (YoY) from ₹177.6 crore in…
- C.E. Info Systems Ltd (Q2 FY26)
IoT-led business growth is robust, with a 50% revenue increase from INR 54 crores to INR 74.5 crores year-on-year. Key concall takeaways from C.E. Info Systems…
Arthneeti Pro · Annual
Quick Heal Technologies Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Quick Heal Technologies Ltd Q2 FY26 results?
Enterprise business is expected to become the dominant revenue contributor soon, overtaking Consumer business, which is structurally declining. Quick Heal Technologies expects steady growth driven by both Consumer and Enterprise segments, with Enterprise set to take a larger revenue share soon (currently around 60-40 split).
What is Quick Heal Technologies Ltd share price analysis?
Quick Heal Technologies Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹830 Cr. Investors should review the full earnings analysis for detailed insights.
Is Quick Heal Technologies Ltd planning capital expenditure?
The company maintains a strong balance sheet with INR 191 crores cash balance as of 30th September 2025, offering flexibility for investments.
Keep Quick Heal Technologies Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.